378 related articles for article (PubMed ID: 33919601)
1. The Importance of Cardiac T2* Magnetic Resonance Imaging for Monitoring Cardiac Siderosis in Thalassemia Major Patients.
Chaosuwannakit N; Makarawate P; Wanitpongpun C
Tomography; 2021 Apr; 7(2):130-138. PubMed ID: 33919601
[No Abstract] [Full Text] [Related]
2. Low prevalence of cardiac siderosis in heavily iron loaded Egyptian thalassemia major patients.
El Beshlawy A; El Tagui M; Hamdy M; El Ghamrawy M; Azim KA; Salem D; Said F; Samir A; St Pierre T; Pennell DJ
Ann Hematol; 2014 Mar; 93(3):375-9. PubMed ID: 23949317
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: a 6-year study.
Ambati SR; Randolph RE; Mennitt K; Kleinert DA; Weinsaft JW; Giardina PJ
Am J Hematol; 2013 Aug; 88(8):652-6. PubMed ID: 23640778
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging.
Wahidiyat PA; Liauw F; Sekarsari D; Putriasih SA; Berdoukas V; Pennell DJ
Hematology; 2017 Sep; 22(8):501-507. PubMed ID: 28218005
[TBL] [Abstract][Full Text] [Related]
5. Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major.
Mokhtar GM; Sherif EM; Habeeb NM; Abdelmaksoud AA; El-Ghoroury EA; Ibrahim AS; Hamed EM
Hematology; 2016 Jan; 21(1):46-53. PubMed ID: 26288192
[TBL] [Abstract][Full Text] [Related]
6. Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.
Tanner MA; Galanello R; Dessi C; Smith GC; Westwood MA; Agus A; Pibiri M; Nair SV; Walker JM; Pennell DJ
J Cardiovasc Magn Reson; 2008 Feb; 10(1):12. PubMed ID: 18298856
[TBL] [Abstract][Full Text] [Related]
7. Cardiac T2* MRI assessment in patients with thalassaemia major and its effect on the preference of chelation therapy.
Akcay A; Salcioglu Z; Oztarhan K; Tugcu D; Aydogan G; Ayaz NA; Bornaun H; Sen HS; Akici F; Akdana B
Int J Hematol; 2014 Jun; 99(6):706-13. PubMed ID: 24719246
[TBL] [Abstract][Full Text] [Related]
8. Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients.
Ouederni M; Ben Khaled M; Mellouli F; Ben Fraj E; Dhouib N; Yakoub IB; Abbes S; Mnif N; Bejaoui M
Ann Hematol; 2017 Jan; 96(1):133-139. PubMed ID: 27730342
[TBL] [Abstract][Full Text] [Related]
9. Five Years of Deferasirox Therapy for Cardiac Iron in β-Thalassemia Major.
Vlachaki E; Agapidou A; Spanos G; Klonizakis P; Vetsiou E; Mavroudi M; Boura P
Hemoglobin; 2015; 39(5):299-304. PubMed ID: 26177199
[TBL] [Abstract][Full Text] [Related]
10. The relationship between the myocardial T2* value and left ventricular volumetric and functional parameters in thalassemia major patients.
Bayraktaroğlu S; Aydinok Y; Yildiz D; Uluer H; Savaş R; Alper H
Diagn Interv Radiol; 2011 Dec; 17(4):346-51. PubMed ID: 21647857
[TBL] [Abstract][Full Text] [Related]
11. [Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].
Wu X; Jing Y; Pei F; Chen J; Feng X; He Y; Zhang Y; Li C
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):249-52. PubMed ID: 23443782
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of calcium channel blockers plus iron chelation therapy versus chelation therapy only on iron overload in children and young adults with transfusion-dependent thalassemia: A randomized double-blind placebo-controlled trial.
Gupta V; Kumar I; Raj V; Aggarwal P; Agrawal V
Pediatr Blood Cancer; 2022 Jun; 69(6):e29564. PubMed ID: 35092347
[TBL] [Abstract][Full Text] [Related]
13. How early can myocardial iron overload occur in beta thalassemia major?
Yang G; Liu R; Peng P; Long L; Zhang X; Yang W; Tan S; Pan H; Long X; He T; Anderson L; Lai Y
PLoS One; 2014; 9(1):e85379. PubMed ID: 24465548
[TBL] [Abstract][Full Text] [Related]
14. Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2* study.
Roghi A; Cappellini MD; Wood JC; Musallam KM; Patrizia P; Fasulo MR; Cesaretti C; Taher AT
Ann Hematol; 2010 Jun; 89(6):585-9. PubMed ID: 20016898
[TBL] [Abstract][Full Text] [Related]
15. comparison of effects of different long-term iron-chelation regimens on myocardial and hepatic iron concentrations assessed with T2* magnetic resonance imaging in patients with beta-thalassemia major.
Perifanis V; Christoforidis A; Vlachaki E; Tsatra I; Spanos G; Athanassiou-Metaxa M
Int J Hematol; 2007 Dec; 86(5):385-9. PubMed ID: 18192103
[TBL] [Abstract][Full Text] [Related]
16. [Study of iron overload assessment by T2* magnetic resonance imaging in patients with myelodysplastic syndromes].
Song LL; Lu HY; Xiao C; Wu LY; Wu D; Su JY; Zhou LY; Chang CK
Zhonghua Xue Ye Xue Za Zhi; 2019 Mar; 40(3):222-226. PubMed ID: 30929390
[No Abstract] [Full Text] [Related]
17. Evaluation of cardiac iron load by cardiac magnetic resonance in thalassemia.
Merchant R; Joshi A; Ahmed J; Krishnan P; Jankharia B
Indian Pediatr; 2011 Sep; 48(9):697-701. PubMed ID: 21169646
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Tissue Elastography With Magnetic Resonance Imaging T2* and Serum Ferritin Quantification in Detecting Liver Iron Overload in Patients With Thalassemia Major.
Pipaliya N; Solanke D; Parikh P; Ingle M; Sharma R; Sharma S; Sawant P
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):292-298.e1. PubMed ID: 27650324
[TBL] [Abstract][Full Text] [Related]
19. Correlation of serum ferritin levels with hepatic MRI T2 and liver iron concentration in nontransfusion beta-thalassemia intermediate patients: A contemporary issue.
Karimi M; Amirmoezi F; Haghpanah S; Ostad S; Lotfi M; Sefidbakht S; Rezaian S
Pediatr Hematol Oncol; 2017 Aug; 34(5):292-297. PubMed ID: 29190176
[TBL] [Abstract][Full Text] [Related]
20. The relationships between pancreatic T2* values and pancreatic iron loading with cardiac dysfunctions, hepatic and cardiac iron siderosis among Egyptian children and young adults with β-thalassaemia major and sickle cell disease: a cross-sectional study.
Salama K; Abdelsalam A; Eldin HS; Youness E; Selim Y; Salama C; Hassanein G; Samir M; Zekri H
F1000Res; 2020; 9():1108. PubMed ID: 34249348
[No Abstract] [Full Text] [Related]
[Next] [New Search]
